• Ticker

    Advertisement Find a Broker - Visit the DailyFinance Broker Center
DJIA 12,454.83 -74.92 -0.60%
NASDAQ 2,837.53 -1.85 -0.07%
S&P 500 1,317.82 -2.86 -0.22%

$4.50 $0.02 (0.45%)

REAL-TIME: Last trade at

Celldex Therapeutics, Inc.

NASDAQ:CLDX

Jump to this page for:

Related Resources

Biotech Stock Mailbag: ASCO, Celldex, Obesity Drug Game-Changer

5/25/2012 by TheStreet.com

BreakoutStocks.com Reports 3 Penny Stocks Leading in Volume in Thursday's Market - Celldex Therapeutics, Patriot Coal Corporation, Jetblue Airways Corp

5/24/2012 by PRWeb

Celldex gaps up, resistance is at the $4.78 pivot high

5/24/2012 by Theflyonthewall.com

Celldex rises 7.7%

5/24/2012 by Theflyonthewall.com

Celldex data not negative, says Oppenheimer

5/24/2012 by Theflyonthewall.com

Celldex’s CDX-011 Demonstrates High Response Rates in Patients with Metastatic Breast Cancer Expressing Elevated Levels of GPNMB and in Triple Negative Disease

5/24/2012 by PharmiWeb.com - UK

Celldex Therapeutics (CLDX) Announces 'High Response' CDX-011 Trial Data

5/23/2012 by StreetInsider.com

Celldex Therapeutics Breast Cancer Drug Shows Strong Results, But Only In Some Patients

5/23/2012 by Forbes

Celldex Targeted Drug Shrinks Breast Cancer

5/23/2012 by TheStreet.com

Celldex’s CDX-011 Demonstrates High Response Rates in Patients with Metastatic Breast Cancer Expressing Elevated Levels of GPNMB and in Triple Negative Disease

5/23/2012 by Business Wire

Celldex volatility elevated into topline results of the Phase 2b EMERGE study

5/21/2012 by Theflyonthewall.com

Celldex Therapeutics to Host Call to Announce Topline Results from the EMERGE Study in Advanced Breast Cancer

5/18/2012 by PharmiWeb.com - UK

Celldex to host conference call

5/18/2012 by Theflyonthewall.com

Celldex Therapeutics to Host Call to Announce Topline Results from the EMERGE Study in Advanced Breast Cancer

5/18/2012 by Business Wire

An Early Look at 2012 ASCO Biotech Cancer Stocks (DNDN, LLY, AMGN, ARIA, ARQL, ARRY, AVEO, BVTI, ABPI, BMY, CLDX, CYTR, CYCC, GALE, EXEL, GNBT, GHDX, IMGN, MYGN, NKTR, NLNK, ONXX, OPTR, PCYC, SGEN, SNSS, SNTA)

5/18/2012 by 24/7 Wall Street

7 Stocks Under $10 Making Big Moves

5/17/2012 by TheStreet.com

Biotech Stock Live Chat: ASCO & Obesity

5/17/2012 by TheStreet.com

5 Biotechnology Stocks With Upcoming Catalysts

5/16/2012 by Seeking Alpha

Celldex Therapeutics Added to Nasdaq Biotechnology Index

5/15/2012 by PharmiWeb.com - UK

Celldex Therapeutics Added to Nasdaq Biotechnology Index

5/15/2012 by Business Wire

NASDAQ Changes Up Biotech Index Members & Weightings

5/14/2012 by 24/7 Wall Street

Taking An Early Look at 2012 ASCO Biotech/Cancer Stocks (DNDN, LLY, ARIA, ARRY, BVTI, ABPI, CLDX, CYTR, GALE, EXEL, GNBT, GHDX, IMGN, NKTR, NLNK, PCYC, SGEN)

5/10/2012 by 24/7 Wall Street

Celldex reports Q1 EPS (27c) , consensus (24c)

5/3/2012 by Theflyonthewall.com

Celldex Announces Plans to Release Topline Results from the EMERGE Study in Advanced Breast Cancer

5/1/2012 by PharmiWeb.com - UK

Celldex: Preparing To EMERGE

5/1/2012 by RTTNews

Bio-Pharma Catalyst Trades: Focus On MediciNova

5/1/2012 by Seeking Alpha

Celldex Announces Plans to Release Topline Results from the EMERGE Study in Advanced Breast Cancer

5/1/2012 by Business Wire

2 Biotech Stocks On Sale

4/30/2012 by Seeking Alpha

Bio Pharma Wrap Up From Last Week And One ASCO Catalyst Short Term Pick

4/30/2012 by Seeking Alpha

Global Veterinary Vaccines Industry

4/17/2012 by PR Newswire

Biotech Stock Mailbag: All You Need to Know About Hep C Drugs

4/13/2012 by TheStreet.com

Celldex management to meet with Jefferies

4/4/2012 by Theflyonthewall.com

Cantor Fitzgerald Starts Celldex Therapeutics (CLDX) at Buy; Valuation Not Reflecting Depth

4/4/2012 by StreetInsider.com

Celldex initiated with a Buy at Cantor

4/3/2012 by Theflyonthewall.com

Celldex Has Big Expectations For ASCO-12

3/29/2012 by Seeking Alpha

Celldex trades up in the pre-market, resistance is at $5.17

3/21/2012 by Theflyonthewall.com

Celldex moves higher in pre-market, resistance is at $5.17

3/20/2012 by Theflyonthewall.com

Celldex: Buy The Rumor, Sell The News Into ASCO

3/19/2012 by Seeking Alpha

Research and Markets: Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2012

3/19/2012 by Business Wire

Biotech Stock Live Chat

3/15/2012 by TheStreet.com
See More Articles...